阿司匹林
医学
凝血噁烷
心肌梗塞
抗凝剂
药品
疾病
环氧合酶
药理学
重症监护医学
血小板
内科学
血栓素
酶
生物化学
生物
作者
Jolanta Hybiak,Izabela Broniarek,Gerard Kiryczyński,Laura.D. Los,Jakub Rosik,Filip Machaj,Hubert Sławiński,Kornelia Jankowska,Elżbieta Urasińska
标识
DOI:10.1016/j.ejphar.2019.172762
摘要
Aspirin (acetylsalicylic acid), the oldest synthetic drug, was originally used as an anti-inflammatory medication. Being an irreversible inhibitor of COX (prostaglandin-endoperoxide synthase) enzymes that produce precursors for prostaglandins and thromboxanes, it has gradually found several other applications. Sometimes these applications are unrelated to its original purpose for example its use as an anticoagulant. Applications such as these have opened opportunities for new treatments. In this case, it has been tested in patients with cardiovascular disease to reduce the risk of myocardial infarct. Its function as an anticoagulant has also been explored in the prophylaxis and treatment of pre-eclampsia, where due to its anti-inflammatory properties, aspirin intake may be used to reduce the risk of colorectal cancer. It is important to always consider both the risks and benefits of aspirin's application. This is especially important for proposed use in the prevention and treatment of neurologic ailments like Alzheimer's disease, or in the prophylaxis of myocardial infarct. In such cases, the decision if aspirin should be applied, and at what dose may be guided by specific molecular markers. In this revived paper, the pleiotropic application of aspirin is summarized.
科研通智能强力驱动
Strongly Powered by AbleSci AI